| Name | Title | Contact Details |
|---|---|---|
Jeff Debrosse |
Chief Technology Officer | Profile |
Turn 14 Distribution is a Performance Warehouse Distributor with distribution facilities strategically located in Hatfield, PA, Arlington, TX, Reno, NV, and Indianapolis, IN. Turn 14 Distributions strategy consists of catering to niche vehicle markets, along with stocking its partner manufacturers full product lines for quick order fulfillment. Exclusive Turn 14 Distribution promotions ensure that products are marketed efficiently and correctly to each suppliers target audience. The company relies upon its dedicated sales specialists—chosen for their experience in each particular market—to service its customers with superior knowledge. In addition, the companys website offers lens technology to permit customers to view the products available for each individual market most efficiently. Turn 14 Distributions up-to-the-minute online inventory tracking, efficient forecasting, and dedicated Customer Support Department allow the company to cut lead times and keep its customers informed about product fulfillment. The companys goal is to provide its customers the sales, marketing, and post-sales support needed to succeed in the modern marketplace. With 1,500,000 sq ft of modern distribution center space, Turn 14 Distribution boasts ground shipping coverage to 60% of the U.S. population in one day and 100% within two days. Globally, Turn 14 Distributions competitive freight rates, ship to your shop flat rate shipping, late shipping cutoff times, seven-day-a-week operation, and same day in-stock order fulfillment commitment enable it to service customers both across the United States and the world efficiently.
Ascend empowers entrepreneurial CPAs to reach their goals with an innovative growth model that brings their firms into the new age. Backed by private equity from people-focused Alpine Investors, Ascend is building a modern platform for regional accounting firms that enables them to stay independent while accessing the resources of a large CPA firm to help them grow. Ascend provides access to growth capital, robust talent acquisition, best-of-breed technology, a catalytic leadership system, shared back-office services, and modernized equity incentives so that firms can surmount todays industry challenges and reach their full potential. Founded in January 2023, the company attained revenues sufficient to qualify it as a Top 100 U.S. accounting firm within six months of operation.
Integrated Metal Components, Inc. is a precision sheet metal manufacturing and engineering shop located just south of Portland, Oregon in the city of Tualatin. We are here to serve all your sheet metal manufacturing, engineering, and integrated assembly needs. IMC is committed to producing the highest quality products in the industry. We achieve this by setting superior standards for production and service. Give us a call today to discuss your next project!
Rivian Automotive, Inc. is an American electric vehicle manufacturer founded in 2009 by Robert "RJ" Scaringe. Headquartered in Irvine, California, Rivian focuses on producing electric trucks and SUVs designed for sustainability. Its flagship models include the R1T, an all-electric pickup truck, and the R1S, an all-electric SUV, both known for their powerful electric motors and impressive performance capabilities. In addition to vehicle manufacturing, Rivian develops automotive technology, particularly in electric drivetrains and autonomous driving systems. The company is also exploring opportunities in ride-sharing and driverless car markets. Rivian has garnered significant investment from major corporations, including Amazon, which has placed large orders for electric delivery vans, and Ford Motor Company. With a strong focus on innovation and sustainability, Rivian aims to meet the growing demand for electric vehicles in both consumer and commercial markets.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.